NL301177I2 - tecovirimat of een farmaceutisch aanvaardbaar zout daarvan - Google Patents
tecovirimat of een farmaceutisch aanvaardbaar zout daarvanInfo
- Publication number
- NL301177I2 NL301177I2 NL301177C NL301177C NL301177I2 NL 301177 I2 NL301177 I2 NL 301177I2 NL 301177 C NL301177 C NL 301177C NL 301177 C NL301177 C NL 301177C NL 301177 I2 NL301177 I2 NL 301177I2
- Authority
- NL
- Netherlands
- Prior art keywords
- tecovirimat
- pharmaceutically acceptable
- acceptable salt
- salt
- pharmaceutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48018203P | 2003-06-20 | 2003-06-20 | |
| PCT/US2004/019552 WO2004112718A2 (en) | 2003-06-20 | 2004-06-18 | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL301177I1 NL301177I1 (nl) | 2022-06-08 |
| NL301177I2 true NL301177I2 (nl) | 2022-08-23 |
Family
ID=33539267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL301177C NL301177I2 (nl) | 2003-06-20 | 2022-06-02 | tecovirimat of een farmaceutisch aanvaardbaar zout daarvan |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1638938B1 (nl) |
| JP (2) | JP4884216B2 (nl) |
| AU (1) | AU2004249250C1 (nl) |
| BE (1) | BE2022C521I2 (nl) |
| CA (1) | CA2529761C (nl) |
| DK (1) | DK1638938T3 (nl) |
| ES (1) | ES2632313T3 (nl) |
| FR (1) | FR22C1022I1 (nl) |
| NL (1) | NL301177I2 (nl) |
| PL (1) | PL1638938T3 (nl) |
| WO (1) | WO2004112718A2 (nl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007351866C1 (en) * | 2003-06-20 | 2013-07-25 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| US7737168B2 (en) * | 2003-06-20 | 2010-06-15 | Siga Technologies, Inc. | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| US8530509B2 (en) | 2003-06-20 | 2013-09-10 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| AU2012268859B2 (en) * | 2003-06-20 | 2016-05-05 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| ES2632313T3 (es) * | 2003-06-20 | 2017-09-12 | Siga Technologies Inc. | Compuestos, composiciones y métodos para el tratamiento y la prevención de infecciones por ortopoxvirus y enfermedades asociadas |
| RU2386617C2 (ru) * | 2004-08-30 | 2010-04-20 | Янссен Фармацевтика Н.В. | ПРОИЗВОДНЫЕ ТРИЦИКЛИЧЕСКОГО ЛАКТАМА В КАЧЕСТВЕ ИНГИБИТОРОВ 11-β-ГИДРОКСИСТЕРОИДНОЙ ДЕГИДРОГЕНАЗЫ |
| US7994221B2 (en) | 2004-12-06 | 2011-08-09 | Siga Technologies, Inc. | Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| JP5285276B2 (ja) | 2004-12-06 | 2013-09-11 | シガ テクノロジーズ，インコーポレーテッド | アレナウイルスに関連した感染をはじめとする出血熱ウイルスを処置するための、スルホニルセミカルバジド、セミカルバジドおよび尿素、その医薬組成物および方法 |
| US8410149B2 (en) | 2004-12-06 | 2013-04-02 | Siga Technologies Inc. | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| US20070003608A1 (en) * | 2005-04-08 | 2007-01-04 | Almond Merrick R | Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| JP2008535862A (ja) * | 2005-04-08 | 2008-09-04 | キメリクス，インコーポレイテッド | ポックスウイルス感染の治療のための化合物、組成物および方法 |
| EP3085377A1 (en) | 2008-01-25 | 2016-10-26 | Chimerix, Inc. | Methods of treating viral infections |
| WO2011011519A1 (en) | 2009-07-21 | 2011-01-27 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
| WO2011100698A2 (en) | 2010-02-12 | 2011-08-18 | Chimerix, Inc. | Methods of treating viral infection |
| JP6018041B2 (ja) | 2010-03-23 | 2016-11-02 | シガ・テクノロジーズ・インコーポレーテッド | Ｓｔ−２４６の多形型および調製方法 |
| WO2011139709A2 (en) | 2010-04-26 | 2011-11-10 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
| EP2600715B1 (en) | 2010-08-05 | 2019-12-11 | Siga Technologies, Inc. | St-246 liquid formulations and methods |
| CN101906064A (zh) * | 2010-08-09 | 2010-12-08 | 中国人民解放军军事医学科学院微生物流行病研究所 | St-246的立体异构体的制备方法 |
| CA3183432A1 (en) | 2012-08-16 | 2014-02-20 | Siga Technologies, Inc. | Methods of preparing tecovirimat |
| CN111635353A (zh) * | 2013-07-19 | 2020-09-08 | 西佳技术公司 | 非晶形特考韦瑞制备 |
| WO2023192782A2 (en) * | 2022-03-27 | 2023-10-05 | Board Of Regents, The University Of Texas System | Small molecule inhibitors of lanosterol synthase |
| CN116730995B (zh) * | 2022-08-12 | 2024-06-25 | 深圳微芯生物科技股份有限公司 | 一类酰肼类化合物、其制备方法及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906755A (en) * | 1956-11-16 | 1959-09-29 | Schenley Ind Inc | N-acyl derivatives of alpha-pyridine carboxylic acid hydrazide |
| US4061763A (en) * | 1975-05-09 | 1977-12-06 | Merck & Co., Inc. | Tricyclicdicarboximides |
| JPS5247844A (en) * | 1975-10-15 | 1977-04-16 | Ube Ind Ltd | Elastomer compositions |
| JPS6483065A (en) * | 1987-09-25 | 1989-03-28 | Hitachi Chemical Co Ltd | Endo-cis-3,6-cyclopropylene-tetra(or hexa)hydrophthalic acid imide derivative and antiarhythmic agent |
| US5068356A (en) * | 1990-02-20 | 1991-11-26 | Atochem North America, Inc. | Hindered phenolic n-(amido)imides |
| US6433016B1 (en) | 2001-01-12 | 2002-08-13 | Vassil Stefanov Georgiev | Drugs for treating viral infections |
| US6596771B2 (en) | 2001-01-12 | 2003-07-22 | Schering Corporation | Drugs for treating viral infections |
| US20040087548A1 (en) * | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| ES2632313T3 (es) * | 2003-06-20 | 2017-09-12 | Siga Technologies Inc. | Compuestos, composiciones y métodos para el tratamiento y la prevención de infecciones por ortopoxvirus y enfermedades asociadas |
-
2004
- 2004-06-18 ES ES04776765.2T patent/ES2632313T3/es not_active Expired - Lifetime
- 2004-06-18 AU AU2004249250A patent/AU2004249250C1/en not_active Expired
- 2004-06-18 CA CA2529761A patent/CA2529761C/en not_active Expired - Lifetime
- 2004-06-18 DK DK04776765.2T patent/DK1638938T3/en active
- 2004-06-18 EP EP04776765.2A patent/EP1638938B1/en not_active Expired - Lifetime
- 2004-06-18 PL PL04776765T patent/PL1638938T3/pl unknown
- 2004-06-18 WO PCT/US2004/019552 patent/WO2004112718A2/en active Application Filing
- 2004-06-18 JP JP2006517409A patent/JP4884216B2/ja not_active Expired - Lifetime
-
2011
- 2011-08-18 JP JP2011179109A patent/JP5657489B2/ja not_active Expired - Lifetime
-
2022
- 2022-05-30 BE BE2022C521C patent/BE2022C521I2/nl unknown
- 2022-06-02 FR FR22C1022C patent/FR22C1022I1/fr active Active
- 2022-06-02 NL NL301177C patent/NL301177I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004112718A2 (en) | 2004-12-29 |
| EP1638938A4 (en) | 2008-09-17 |
| WO2004112718A3 (en) | 2005-04-07 |
| JP2011252019A (ja) | 2011-12-15 |
| PL1638938T3 (pl) | 2017-10-31 |
| AU2004249250B2 (en) | 2011-09-01 |
| CA2529761A1 (en) | 2004-12-29 |
| JP5657489B2 (ja) | 2015-01-21 |
| AU2004249250C1 (en) | 2012-04-12 |
| EP1638938B1 (en) | 2017-04-12 |
| JP2007521273A (ja) | 2007-08-02 |
| ES2632313T3 (es) | 2017-09-12 |
| FR22C1022I1 (fr) | 2022-07-22 |
| AU2004249250A1 (en) | 2004-12-29 |
| EP1638938A2 (en) | 2006-03-29 |
| DK1638938T3 (en) | 2017-07-31 |
| CA2529761C (en) | 2013-08-13 |
| NL301177I1 (nl) | 2022-06-08 |
| JP4884216B2 (ja) | 2012-02-29 |
| BE2022C521I2 (nl) | 2024-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301177I2 (nl) | tecovirimat of een farmaceutisch aanvaardbaar zout daarvan | |
| NL301158I2 (nl) | Relugolix of een zout daarvan | |
| NL300865I2 (nl) | Eluxadoline of een farmaceutisch aanvaardbaar zout ervan | |
| NL301106I1 (nl) | Cenobamaat of een farmaceutisch aanvaardbaar zout daarvan | |
| NL350091I2 (nl) | Cyantraniliprole of een zout daarvan | |
| FIC20240007I1 (fi) | Gefapiksantti tai sen farmaseuttisesti hyväksyttävä suola | |
| NL350108I2 (nl) | Isofetamid of een zout daarvan | |
| NL300640I2 (nl) | Alogliptine of een farmaceutisch aanvaardbaar zout daarvan | |
| NL300974I2 (nl) | Binimetinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat | |
| NL301209I2 (nl) | capmatinib of een farmaceutisch aanvaardbaar zout daarvan | |
| NL301003I2 (nl) | Sotagliflozin of een farmaceutisch aanvaardbaar zout daarvan | |
| NL300993I2 (nl) | Apalutamide of een farmaceutisch aanvaardbaar zout daarvan | |
| NL300863I2 (nl) | Palbociclib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout | |
| NL300895I2 (nl) | Rolapitant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, met inbegrip van rolapitant hydrochloridemonohydraat | |
| NL301042I1 (nl) | Trifaroteen, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout | |
| NL301020I2 (nl) | Avatrombopag, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder avatrombopag-maleaat | |
| NL301037I2 (nl) | Solriamfetol of een farmaceutisch aanvaardbaar zout daarvan, bij voorkeur het hydrochloridezout daarvan | |
| NL300913I2 (nl) | Cariprazine, optioneel in de vorm van een zout, waaronder cariprazine hydrochloride | |
| FIC20210017I1 (fi) | Kabotegraviiri tai sen farmaseuttisesti hyväksyttävä suola tai solvaatti | |
| NL301202I1 (nl) | Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline | |
| NL300703I2 (nl) | Simeprevir, of een farmaceutisch aanvaardbaar zout daarvan, waaronder simeprevirnatrium. | |
| NL350079I2 (nl) | Pyriofenone of een zout daarvan | |
| DK2266650T3 (da) | Lægemiddeldispenser | |
| NO2009013I2 (no) | Laropiprant eller et farmasøytisk akseptabelt saltderav | |
| DE602004017700D1 (de) | Transmukosen verabreichung |